ClearPoint Neuro to commercialize FDA-cleared neuro laser

The ClearPoint Prism neuro laser therapy system [Image courtesy of ClearPoint Neuro]ClearPoint Neuro (Nasdaq: CLPT) announced today that FDA has cleared its Swedish partner Clinical Laserthermia Systems’ neuro laser therapy system.

The plan is for ClearPoint Neuro to commercialize the system as the ClearPoint Prism. The company has exclusive global rights to commercialize the CLS magnetic resonance (MR) guided laser interstitial thermal therapy (MRgLITT) system. The system is for neuro applications.

The ClearPoint Neuro navigation system has FDA clearance and a CE mark. The company has it installed in over 60 active sites in the United States, Canada, and Europe. In addition, the company has partnerships with more than 45 pharmaceutical and biotech companies. Applications it’s pursuing include drug delivery to the brain. Also, ClearPoint Neuro is active in the hot brain-computer interface space. It is working with Blackrock Neurotech to automate BCI im…

Read more
  • 0

7 brain-computer interface companies you need to know

[Image from Milad Fakurian on Unsplash] Blackrock Neurotech, BrainGate, ClearPoint Neuro, Neuralink, Synchron and more race to bring brain-computer interface (BCI) tech to market.

They’re using a multitude of methods —  and developing their own systems that would allow patients to control a computer with their brain.

Such technology could potentially enable countless immobile people someday to control a mouse cursor, keyboard, mobile device/tablet, wheelchair or prosthetic device by only thinking.

The FDA last year issued leapfrog guidance for nonclinical testing and study design related to implanted brain-computer interface (BCI) devices. Leapfrog guidance allows the agency to share its initial thoughts on emerging technologies that are early in development but appear likely to be of importance to public health.

Companies have faced a number of challenges as they try to bring brain-computer interface technology to the market, but they continue to …

Read more
  • 0

Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials

Blackrock Neurotech’s Utah array is used in its brain-computer interface implant to sense brain signals [Photo courtesy of Blackrock]

Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home.

A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year.

Salt Lake City-based Blackrock plans to submit its first commercial BCI device, called MoveAgain, to the FDA this year.

Blackrock wants its BCI platform to be the first one that’s commercially available to people with paralysis. Its implant has been used in patients since 2004 through research studies, with zero FDA-reported serious adverse events since then.

“Through this expansion…

Read more
  • 0

Blackrock Neurotech and ClearPoint Neuro want to automate brain implant surgeries

The Utah Array platform [Image from Blackrock Neurotech/ClearPoint Neuro]ClearPoint Neuro (NSDQ:CLPT) announced an agreement with Blackrock Neurotech to develop automated technologies for brain implant surgeries.

The partnership will seek to develop an automated surgical solution for implanting brain-computer interfaces (BCIs) into patients with neurological disorders including from paralysis, ALS, blindness and hearing loss, among others.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

Blackrock Neurotech and ClearPoint Neuro want to automate brain implant surgeries

The Utah Array platform [Image from Blackrock Neurotech/ClearPoint Neuro]

ClearPoint Neuro (NSDQ:CLPT) announced an agreement with Blackrock Neurotech to develop automated technologies for brain implant surgeries.

The partnership will seek to develop an automated surgical solution for implanting brain-computer interfaces (BCIs) into patients with neurological disorders including from paralysis, ALS, blindness and hearing loss, among others.

Solana Beach, Calif.-based ClearPoint Neuro said in a news release that the partnership aims to leverage its platform and software with Blackrock Neurotech’s Utah Array to deliver a clinical solution for surgeons that is more streamlined and effective than other BCI implantation surgeries performed to date.

Salt Lake City-based Blackrock Neurotech’s Utah Array, touted as the leader in implantable BCIs and the only electrode array of its kind, holds …

Read more
  • 0